• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Pi-Z phenotypes in a pulmonary clinic. Their prevalence and physiologic state.

作者信息

Gerblich A A, Kleinerman J, Rynbrandt D J, Chester E H, Ihrig J

出版信息

Am J Clin Pathol. 1978 May;69(5):509-13. doi: 10.1093/ajcp/69.5.509.

DOI:10.1093/ajcp/69.5.509
PMID:306745
Abstract

A series of 1,458 consecutive patients referred to the Cleveland Veterans Administration Pulmonary Clinic for pulmonary function studies was evaluated for alpha 1-antitrypsin deficiency by determination of serum trypsin inhibitory capacity (STIC). Protease inhibitor (Pi) phenotyping was performed on all sera with STIC values less than 1.6 mg/ml. The following non-MM phenotypes were found: 1FZ, 32MZ, 2ZZ, 3SZ, 5SS, 33MS, 21M. The prevalence of Pi Z heterozygosity is 2.74%. This figure is not significantly greater than that observed in a healthy population. A group ( n = 12) with heterozygous Z phenotype (MZ + SZ) was compared with a control (MM) group (n = 13) matched for age, race and smoking history from this same population. Our findings indicate similar deviations from predicted normal values in both control (MM) and Z-heterozygotic groups for physiologic tests of airway resistance, lung volumes, diffusing capacity, and static and dynamic compliance. There was no significant difference between MM controls and MZ heterozygotes in the physiologic variables measured.

摘要

相似文献

1
Pi-Z phenotypes in a pulmonary clinic. Their prevalence and physiologic state.
Am J Clin Pathol. 1978 May;69(5):509-13. doi: 10.1093/ajcp/69.5.509.
2
Alpha 1-antitrypsin Pi-types in 965 COPD patients.965例慢性阻塞性肺疾病患者的α1-抗胰蛋白酶Pi型
Chest. 1986 Mar;89(3):370-3. doi: 10.1378/chest.89.3.370.
3
The Effects of Rare Variants on Lung Function and Emphysema in SPIROMICS.SPIROMICS 中罕见变异对肺功能和肺气肿的影响。
Am J Respir Crit Care Med. 2020 Mar 1;201(5):540-554. doi: 10.1164/rccm.201904-0769OC.
4
Assessment of alpha-1-antitrypsin deficiency heterozygosity as a risk factor in the etiology of emphysema. Physiological comparison of adult normal and heterozygous protease inhibitor phenotype subjects from a random population.评估α-1抗胰蛋白酶缺乏杂合性作为肺气肿病因中的一个风险因素。对来自随机人群的成年正常和杂合蛋白酶抑制剂表型受试者进行生理比较。
J Clin Invest. 1979 Feb;63(2):299-309. doi: 10.1172/JCI109303.
5
Variability of pulmonary function in alpha-1-antitrypsin deficiency: clinical correlates.α1抗胰蛋白酶缺乏症患者肺功能的变异性:临床相关性
Ann Intern Med. 1989 Dec 15;111(12):982-91. doi: 10.7326/0003-4819-111-12-982.
6
Interrelationships between neutrophil elastase, serum alpha, -antitrypsin, lung function and chest radiography in patients with chronic airflow obstruction.慢性气流阻塞患者中性粒细胞弹性蛋白酶、血清α1-抗胰蛋白酶、肺功能及胸部X线检查之间的相互关系
Am Rev Respir Dis. 1979 Jul;120(1):31-40. doi: 10.1164/arrd.1979.120.1.31.
7
Heterozygosity in the Pi-system as a pathogenetic cofactor in chronic obstructive pulmonary disease (COPD).Pi系统中的杂合性作为慢性阻塞性肺疾病(COPD)的致病辅助因素。
Eur J Respir Dis. 1985 Apr;66(4):284-96.
8
Protease inhibitor phenotype BsaskatoonM is not associated with emphysema - a 20-year follow-up study.蛋白酶抑制剂表型BsaskatoonM与肺气肿无关——一项20年的随访研究。
Can Respir J. 1999 Sep-Oct;6(5):407-11. doi: 10.1155/1999/409016.
9
Collaborative study to assess risk of lung disease in Pi MZ phenotype subjects.评估Pi MZ表型受试者肺部疾病风险的合作研究。
Am Rev Respir Dis. 1984 Sep;130(3):386-90. doi: 10.1164/arrd.1984.130.3.386.
10
Family study of alpha 1-antitrypsin deficiency: effects of cigarette smoking, measured genotype, and their interaction on pulmonary function and biochemical traits.α1-抗胰蛋白酶缺乏症的家系研究:吸烟、测量基因型及其相互作用对肺功能和生化特征的影响。
Genet Epidemiol. 1992;9(5):317-31. doi: 10.1002/gepi.1370090504.

引用本文的文献

1
Estimated Prevalence and Number of PiMZ Genotypes of Alpha-1 Antitrypsin in Seventy-Four Countries Worldwide.全球 74 个国家中 PiMZ 基因型 α-1 抗胰蛋白酶的估计流行率和数量。
Int J Chron Obstruct Pulmon Dis. 2021 Sep 17;16:2617-2630. doi: 10.2147/COPD.S327803. eCollection 2021.
2
COPD in individuals with the PiMZ alpha-1 antitrypsin genotype.PiMZ 基因型个体的 COPD。
Eur Respir Rev. 2017 Oct 25;26(146). doi: 10.1183/16000617.0068-2017. Print 2017 Dec 31.
3
Chronic obstructive pulmonary disease in alpha1-antitrypsin PI MZ heterozygotes: a meta-analysis.
α1-抗胰蛋白酶PI MZ杂合子中的慢性阻塞性肺疾病:一项荟萃分析。
Thorax. 2004 Oct;59(10):843-9. doi: 10.1136/thx.2004.022541.
4
Frequency and significance of phenotypes for alpha1-antitrypsin deficiency in type 1 autoimmune hepatitis.1型自身免疫性肝炎中α1抗胰蛋白酶缺乏症的表型频率及意义
Dig Dis Sci. 1998 Aug;43(8):1725-31. doi: 10.1023/a:1018875401612.
5
Idiopathic hemochromotosis and alpha-1-antitrypsin deficiency: coexistence in a family with progressive liver disease in the proband.特发性血色素沉着症与α-1抗胰蛋白酶缺乏症:在先证者患有进行性肝病的一个家族中的共存情况。
Hepatology. 1983 Sep-Oct;3(5):714-8. doi: 10.1002/hep.1840030515.